Product image of Mst Continus (Morphine Sulfate) supplied by GNH India

Mst Continus

Active Ingredient:
Morphine Sulfate
Origin:
EU

Mst Continus (Morphine Sulfate)

Morphine sulfate, the active ingredient in Mst Continus, is an opioid analgesic presented as a oral tablet for oral use. It treats moderate to severe acute pain, chronic cancer pain, and post‑operative pain in adult patients.

GNH India supplies Mst Continus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide. The product complies with EU regulatory standards and is distributed under a controlled schedule for safe clinical use. It is manufactured in accordance with Good Manufacturing Practice (GMP) guidelines.

Manufacturer / TM Owner

Mundipharma Gesellschaft M.B.H.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Morphine sulfate is an opioid analgesic used to manage pain through central nervous system pathways.

  • Moderate to severe acute pain: provides rapid analgesia for short‑term painful episodes.
  • Chronic cancer pain: offers sustained relief for ongoing malignant pain.
  • Post‑operative pain: reduces pain after surgical procedures.
  • Severe chronic non‑cancer pain: used when other analgesics are insufficient.
  • Palliative care pain: helps improve comfort in end‑of‑life patients.

How It Works

  • Morphine sulfate acts as a full agonist at mu‑opioid receptors in the central nervous system. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces calcium influx, and increases potassium efflux, which diminishes neuronal excitability and blocks transmission of nociceptive signals, resulting in analgesia.

Side Effects

Morphine sulfate may cause a range of adverse reactions, varying from mild to life‑threatening.

Common Side Effects

  • Nausea: feeling of sickness often accompanied by an urge to vomit.
  • Constipation: reduced bowel movements due to decreased gastrointestinal motility.
  • Drowsiness: increased sleepiness or reduced alertness.
  • Dry mouth: reduced salivation leading to a parched sensation.

Serious or Rare Side Effects

  • Respiratory depression: slowed or shallow breathing that can be fatal.
  • Severe hypotension: marked drop in blood pressure causing dizziness or fainting.
  • Dependence or addiction: development of physical or psychological reliance on the drug.

Precautions & Warnings

When prescribing morphine sulfate, clinicians should consider several safety measures.

  • Assess pain severity: confirm that opioid therapy is appropriate for the level of pain.
  • Evaluate respiratory function: monitor for signs of respiratory compromise before and during treatment.
  • Monitor for dependence: watch for signs of tolerance, misuse, or addiction.
  • Adjust dose in organ impairment: reduce dosage in patients with hepatic or renal dysfunction.
  • Avoid in known hypersensitivity: do not use if the patient has a documented allergy to morphine or other opioids.
  • Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Morphine sulfate can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome.
  • Central nervous system depressants (e.g., benzodiazepines): additive respiratory depression.
  • Other opioids: increased risk of overdose and profound sedation.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole): may raise morphine plasma levels.
  • Diuretics: can enhance hypotensive effects when combined with morphine.

Frequently Asked Questions

Mst Continus contains morphine sulfate, an opioid analgesic indicated for the relief of moderate to severe acute pain, chronic cancer‑related pain, and pain following surgical procedures. It is prescribed when non‑opioid analgesics are insufficient to control the patient’s discomfort.

Morphine sulfate binds to mu‑opioid receptors in the brain and spinal cord, activating inhibitory pathways that reduce the release of excitatory neurotransmitters. This action decreases neuronal firing and blocks the transmission of pain signals, producing analgesia.

The appropriate dose of Mst Continus is determined by the prescribing clinician based on the patient’s pain intensity, prior opioid exposure, age, organ function, and other individual factors. Dosage adjustments are made to achieve effective pain control while minimizing adverse effects.

The safety of morphine sulfate in pregnancy and lactation is not fully established. It is generally classified as a drug to be used only if the potential benefit justifies the potential risk to the fetus or infant. Clinicians should evaluate each case carefully.

To request Mst Continus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mst Continus (morphine sulfate) is a prototypical strong opioid with a well‑characterized efficacy profile. Compared with weaker opioids such as codeine, morphine provides more potent analgesia but also carries a higher risk of respiratory depression and dependence, requiring careful monitoring.

Mst Continus tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiration date.

Mst Continus is supplied as an oral tablet and is taken by mouth with or without water, as directed by the prescriber. The tablet should be swallowed whole; it is not intended for crushing, chewing, or dissolving unless specifically instructed.

The most serious risks include respiratory depression, severe hypotension, and the potential for physical dependence, tolerance, and addiction. Patients should be monitored closely for signs of these events, especially during dose initiation or after dose increases.

Mst Continus should be avoided in individuals with known hypersensitivity to morphine or other opioids, in patients currently taking monoamine oxidase inhibitors, and in those with severe respiratory insufficiency or uncontrolled asthma unless the benefits outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.